SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Among allogeneic haematopoietic stem cell transplant recipients with influenza infection, seasonal influenza vaccination lowers the risk for progression to lower respiratory tract disease.

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

Select gut bacteria protect mice against post-influenza virus secondary bacterial pneumonia, according to a study published ...

Scientists have captured a never-before-seen, high-resolution look at influenza’s stealthy invasion of human cells, revealing that the cells aren’t just helpless victims. Using a groundbreaking ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant that enhances the body's ...

For the first time, researchers have observed live and in high resolution how influenza (“flu”) viruses infect living cells. This was possible thanks to a new microscopy technique, developed at ETH ...

A landmark study reveals that a single oral dose of baloxavir marboxil (baloxavir) significantly reduces the transmission of influenza within households, marking a major advancement in influenza ...